DMMR COLORECTAL CANCER
Clinical trials for DMMR COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new DMMR COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for DMMR COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo trial pulled before it even started
Disease control TerminatedThis was a planned Phase 2 trial to test two immunotherapy drugs—monalizumab and MEDI5752—in people with metastatic cancers that have a specific genetic feature called MSI/dMMR. The study was withdrawn before enrolling any participants, so no data or results are available. The go…
Matched conditions: DMMR COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New test could predict immunotherapy success from live tumor samples
Knowledge-focused OngoingThis observational study collects extra tumor tissue from 416 people with various cancers (bladder, kidney, colorectal, head and neck, liver, lung, skin, endometrial) during routine biopsies. The goal is to develop and train a 'live tumor diagnostic platform' that can predict whe…
Matched conditions: DMMR COLORECTAL CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC